AI assistant
Cibus, Inc. — Director's Dealing 2018
Apr 17, 2018
34396_dirs_2018-04-16_36c25fce-954b-436d-b258-0ef3940dfd7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Calyxt, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2017-07-20
Reporting Person: Bowers Glenn R (Vice President of Breeding)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9040 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.59 | 2026-04-07 | Common Stock (49000) | Direct | |
| Stock Option (Right to Buy) | $13.29 | 2027-06-14 | Common Stock (11760) | Direct |
Footnotes
F1: Includes 7,840 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 45 months. This amended Report is being filed to include 1,200 shares of common stock which were inadvertently omitted from the original Report.
F2: The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on April 7, 2016 and vests 20% on the first anniversary of the grant date, 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.
F3: The Stock Option was granted on June 14, 2017 and vests 15% on the first anniversary of the grant date and 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 45 months.